Explore Trades
All Companies

GEHCCongressional Stock Trades

GE HealthCare Technologies Inc. Common Stock

X-Ray Apparatus & Tubes & Related Irradiation Apparatus

Congressional stock trades in GE HealthCare Technologies Inc. Common Stock (GEHC) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

19

Politicians Trading

4

Last Traded

Aug 3, 2026

Trading History

PartyDemocratRepublican
ChamberHouseSenate✕
TypeBuySell✕
PoliticianNotifiedTradedTypeAmountChange
Ro KhannaDSep 4, 2026Aug 3, 2026Buy$1,001 - $15,000-8.03%
Ro KhannaDAug 7, 2026Jul 30, 2026Buy$1,001 - $15,000-8.31%
Ro KhannaDAug 7, 2026Jul 30, 2026Buy$1,001 - $15,000-8.31%
Ro KhannaDAug 7, 2026Jul 23, 2026Buy$1,001 - $15,000+3.45%
Ro KhannaDAug 7, 2026Jul 21, 2026Buy$1,001 - $15,000+3.37%
Ro KhannaDAug 7, 2026Jul 16, 2026Buy$1,001 - $15,000-2.39%
Ro KhannaDAug 7, 2026Jul 14, 2026Buy$1,001 - $15,000+4.01%
Ro KhannaDAug 7, 2026Jul 13, 2026Buy$1,001 - $15,000-1.81%
Ro KhannaDAug 7, 2026Jul 8, 2026Buy$1,001 - $15,000-0.85%
Ro KhannaDAug 7, 2026Jul 7, 2026Buy$1,001 - $15,000-1.17%
Ro KhannaDAug 7, 2026Jul 6, 2026Buy$1,001 - $15,000-1.10%
Ro KhannaDAug 7, 2026Jul 6, 2026Buy$1,001 - $15,000-1.10%
Ro KhannaDAug 7, 2026Jul 2, 2026Buy$1,001 - $15,000-2.19%
Ro KhannaDAug 7, 2026Jul 2, 2026Buy$1,001 - $15,000-2.19%
Robert BresnahanRMay 31, 2025May 15, 2025Buy$1,001 - $15,000-12.04%
Robert BresnahanRMar 27, 2025Feb 25, 2025Buy$1,001 - $15,000-29.38%

Price History

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).